Amyloidogenic role of cytokine TGF-β1 in transgenic mice and in Alzheimer's disease

Nature

Volumn 389, Issue 6651, 1997, Pages 603-606

  Wyss Coray, Tony ^a   Masliah, Eliezer ^c   Mallory, Margaret ^c   McConlogue, Lisa ^d   Johnson Wood, Kelly ^d   Lin, Carol ^a   Mucke, Lennart ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Athena Neurosciences Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN BLOOD VESSEL; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MENINX; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE; VASCULAR AMYLOIDOSIS;

AGED; AGING; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOIDOSIS; ANIMALS; ASTROCYTES; BRAIN; CEREBRAL AMYLOID ANGIOPATHY; HUMANS; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; THIAZOLES; TRANSFORMING GROWTH FACTOR BETA;

ANIMALIA; MUS MUSCULUS;

EID: 0030764732     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/39321     Document Type: Article

References (30)

1. Selkoe, D. J. Alzheimer's disease: A central role for amyloid. J. Neuropathol. Exp. Neurol. 53, 438-447 (1994).
2. Lendon, C. L., Ashall, F. & Goate, A. M. Exploring the etiology of Alzheimer disease using molecular genetics. J. Am. Med. Assoc. 277, 825-831 (1997).
3. Hardy, J. Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci. 20, 154-159 (1997).
4. Finch, C. E., Laping, N.J., Morgan, T. E., Nichols, N. R. & Pasinetti, G. M. TGF-βl is an organizer of responses to neurodegeneration. J. Cell. Biochem. 53, 314-322 (1993).
5. McCartney-Francis, N. L. & Wahl, S. M. Transforming growth factor β: A matter of life and death. J. Leuk. Biol. 55, 401-409 (1994).
6. van der Wal, E. A., Gómez-Pinilla, F. & Cotman, C. W. Transforming growth factor-β1 is in plaques in Alzheimer and Down pathologies. NeuroReport 4, 69-72 (1993).
7. Chao, C. C. et al. Transforming growth factor β in Alzheimer's disease. Clin. Diag. Lab. Immunol. 1, 109-110 (1994).
8. Peress, N. S. & Perillo, E. Differential expression of TGF-β1, 2 and 3 isotypes in Alzheimer's disease: A comparative immunohistochemical study with cerebral infarction, aged human and mouse control brains. J. Neuropathol. Exp. Neurol. 54, 802-811 (1995).
9. Games, D. et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 373, 523-527 (1995).
10. Masliah, E. et al. Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F β-amyloid precursor protein and Alzheimer's disease. J. Neurosci. 16, 5795-5811 (1996).
11. 42 deposition in a trangenic mouse model of Alzheimer disease. Proc. Natl Acad. Sci. USA 94, 1550-1555 (1997).
12. Wyss-Coray, T. et al. Increased central nervous system production of extracellular matrix components and development of hydrocephalus in transgenic mice overexpressing transforming growth factor-β1. Am. J. Pathol. 147, 53-67 (1995).
13. Fillit, H. & Leveugle, B. Disorders of the extracellular matrix and the pathogenesis of senile dementia of the Alzheimer's type. Lab. Invest. 72, 249-253 (1995).
14. Vinters, H. V. Cerebral amyloid angiopathy. A critical review. Stroke 18, 311-324 (1987).
15. Terry, R. D., Masliah, E. & Hansen, L. A. in Alzheimer's Disease (eds Terry, R. D., Katzman, R. & Bick, K. L.) 179-196 (Raven, New York, 1994).
16. Rockenstein, E. M. et al. Levels and alternative splicing of amyloid β protein precursor (APP) transcripts in brains of transgenic mice and humans with Alzheimer's disease. J. Biol. Chem. 270, 28257-28267 (1995).
17. Hyman, B. T., Tanzi, R.E., Marzloff, K., Barbour, R. & Schenk, D. Kunitz protease inhibitor-containing amyloid β protein precursor immunoreactivity in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 51, 76-83 (1992).
18. Haan, J., Maat-Schieman, M.L. C. & Roos, R. A. C. Clinical aspects of cerebral amyloid angiopathy. Dementia 5, 210-213 (1994).
19. Itoh, Y., Yamada, M., Hayakawa, M., Otomo, E. & Miyatake, T. Crebral amyloid angiopathy: A significant cause of cerebellar as well as lobar cerebral hemorrhage in the elderly. J. Neurol. Sci. 116, 135-141 (1993).
20. Strittmatter, W. J. & Roses, A. D. Apolipoprotein E and Alzheimer's disease. Annu. Rev. Nueorsci. 19, 53-77 (1996).
21. McGeer, P. L. & McGeer, E. G. The inflammatory response system of brain: Implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res. Rev. 21, 195-218 (1995).
22. McGeer, P. L., Schulzer, M. & McGeer, E. G. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: A review of 17 epidemiologic studies. Neurology 47, 425-432 (1996).
23. Mayeux, R. et al. Genetic susceptibility and head injury as risk factors for Alzheimer's disease among community-dwelling elderly persons and their first-degree relatives. Ann. Neurol. 33, 494-501 (1993).
24. Nicoll, J. A. R., Roberts, G.W. & Graham, D. I. Apolipoprotein E ∈4 allele is associated with deposition of amyloid β-protein following head injury. Nature Med. 1, 135-137 (1995).
25. Wisniewski, T. & Frangione, B. Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci. Lett. 135, 235-238 (1992).
26. Schmechel, D. E. et al. Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc. Natl Acad. Sci. USA 90, 9649-9653 (1993).
27. Masliah, E. et al. Spectrum of human immunodeficienty virus-associated neocortical damage. Ann. Neurol. 32, 321-329 (1992).
28. Olichney, J. M. et al. The apolipoprotein E ∈4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant. Neurology 47, 190-196 (1996).
29. Frautschy, S. A., Yang, F., Calderon, L. & Cole, G. M. Rodent models of Alzheimer's disease: rat Aβ infusion approaches to amyloid deposits. Neurobiol. Aging 17, 311-321 (1996).
30. Hsiao, K. et al. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science 274, 99-102 (1996).